VIE/NOVN (VIE/NOVN)

Vienna Stock Exchange: VIE/NOVN · EUR

€141

+1.32 (+0.9%)· Recorded snapshot

Market cap	264B
Revenue (ttm)	50.5B
Net income (ttm)	8.8B
EPS (ttm)	€4.73
P/E (trailing)	29.8x
P/E (forward)	16.1x
Dividend	€4.10 (2.91%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 50.5B
Net income (ttm): 8.8B
EPS (ttm): €4.73
P/E (trailing): 29.8x
P/E (forward): 16.1x
Market cap: 264B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.1

P25 14.3P50 18.7P75 25.4

Trailing P/E29.8

P25 20.4P50 26.7P75 39.7

ROE24.3

P25 4.8P50 10.6P75 20.1

ROIC19.3

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/NOVN indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	AT
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	EUR 299.9B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CH0012005267
Last earnings date	2026-10-27
Last refreshed	2026-10-29
Market cap	EUR 264B
Next earnings date	2027-02-03
Price	EUR 140.76
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/NOVN
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.36%
EV/Earnings	33.95x
EV/EBIT	17.05x
EV/EBITDA	13.64x
EV/FCF	21.75x
EV/Sales	5.79x
FCF / EV yield	4.6%
FCF yield	5.22%
Forward P/E	16.12x
Graham number	43.23736
Graham upside	-69.28%
Lynch fair value	EUR 23.55
Lynch upside	-83.27%
P/(FCF - SBC) ratio	20.64x
P/(OCF - SBC) ratio	18.52x
P/B ratio	7.98x
P/E ratio	29.76x
P/FCF ratio	19.15x
P/OCF ratio	17.3x
P/S ratio	5.23x
Price/EBITDA ratio	12.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.95%
Effective tax rate	20.8%
FCF margin	26.78%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	EUR 117,360
Profitable quarters	107
Profitable years	28
Revenue per employee	EUR 671,141
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth quarters	1
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.5B
Depreciation and amortization	EUR 4.1B
EBIT	EUR 17.2B
EBITDA	EUR 21.2B
EPS	EUR 4.73
Financing cash flow	EUR 685.1M
Free cash flow	EUR 13.8B
Free cash flow minus SBC	EUR 12.8B
Gross profit	EUR 38B
Income taxes	EUR 2.3B
Investing cash flow	EUR -16.5B
Net borrowing	EUR 14.5B
Net cash flow	EUR -604.1M
Net income	EUR 8.8B
Operating cash flow minus SBC	EUR 14.3B
Operating income	EUR 17.2B
Revenue	EUR 50.5B
Stock-based compensation	EUR 1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	EUR 17.36
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	EUR 24.4B
Interest coverage	12.36
Long-term assets	EUR 77.4B
Long-term liabilities	EUR 40.9B
Net cash (debt)	EUR -34.7B
Net cash / market cap	-13.16%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	EUR 11B
Shareholders' equity	EUR 33.1B
Tangible book value	EUR -26.2B
Tangible book value per share	EUR -13.88
Total assets	EUR 103.2B
Total cash	EUR 7.8B
Total debt	EUR 42.5B
Total liabilities	EUR 70.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	EUR 25.8B
Current liabilities	EUR 29.2B
Current ratio	0.88
Inventory turnover	2.27
Net working capital	EUR -2.4B
Quick ratio	0.58
Working capital	EUR -3.3B
Working capital turnover	-13.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-03-12
Dividend payment years	1
Dividend per share	EUR 4.10
Dividend yield	2.91%
Ex-dividend date	2026-03-10
Last dividend	EUR 4.10
Payout ratio	90.4%
Shareholder yield	5.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 130.84
1D price change	0.95%
1M price change	11.08%
1M total return	11.08%
1W price change	3.91%
1W total return	3.91%
1Y price change	26.27%
1Y return CAGR	30.14%
1Y total return	30.12%
20-day SMA	EUR 131.70
200-day SMA	EUR 131.31
3M price change	1.88%
3M total return	1.88%
50-day SMA	EUR 130.02
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 143.52
52-week high date	2026-02-27
52-week low	EUR 105.34
52-week low date	2025-10-29
6M price change	14.22%
6M total return	14.22%
All-time high	EUR 143.52
All-time high date	2026-02-27
All-time low	EUR 94.21
All-time low date	2025-05-12
Average true range (ATR)	EUR 1.73
Average volume	10.6
Change from 52-week high	-1.92%
Change from 52-week low	33.62%
Change from all-time high	-1.92%
Change from all-time low	49.41%
Change from open	0.21%
Day's gap	0.73%
High price	EUR 140.76
Low price	EUR 139.16
Monthly RSI	69.49
Open price	EUR 140.46
Position in 52-week range	100%
Previous close	EUR 139.44
Price vs 150-day SMA	7.58%
Price vs 20-day SMA	6.88%
Price vs 200-day SMA	7.2%
Price vs 50-day SMA	8.26%
Relative volume	2.34
RSI	76.64
Sharpe ratio	1.24
Sortino ratio	1.98
Weekly RSI	59.61
YTD price change	19.09%
YTD total return	22.72%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	36.31%

Deeper analysis on VIE/NOVN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/NOVN report

Is a complete VIE/NOVN research report available?

No complete published report is available for vie/NOVN (VIE/NOVN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/NOVN (VIE/NOVN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/NOVN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/NOVN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/NOVN

Frequently asked questions